In a recent interview, Carolynn DeBenedectis, MD, discussed the utility of AI-enabled slab reconstruction for interpretation of digital breast tomosynthesis (DBT) and new research showing a 13 percent reduction in reading time.
|Articles|May 28, 1997
GE closes purchase of ALI equity
GE this month finalized its acquisition of almost 20% of ultrasound miniPACS developer ALI Technologies of Richmond, British Columbia. The equity purchase was made through GE's subsidiary, General Electric Canada, which bought nearly two million shares
Advertisement
GE this month finalized its acquisition of almost 20% of ultrasound miniPACS developer ALI Technologies of Richmond, British Columbia. The equity purchase was made through GE's subsidiary, General Electric Canada, which bought nearly two million shares of ALI stock. The purchase represents 19.6% of shares in ALI, which also has a technology and marketing agreement with GE Medical Systems of Milwaukee (SCAN 4/2/97).
Advertisement
Related to this article
Keeping defensiveness and ego at bay is just one of the attributes of those who consistently embrace learning from others over the course of one’s life.
Catch up on the top radiology content of the past week.
In a recent interview, Gadi Lalazar, MD, discussed new research demonstrating the capability of natural language processing (NLP) to enhance recognition of incidental hepatic steatosis in ultrasound reports.
Report One, reportedly the first agentic reporting tool specifically geared to breast imaging, is one of three new products that will be showcased by MagView at the upcoming RSNA conference.
Artificial intelligence plaque analysis of CCTA scans showed that 27 percent of former NFL players had severe or extensive total plaque volume, according to a new study to be presented at the American Heart Association Scientific Sessions 2026 this week.
While the P4 trial represents a landmark study on the use of CCTA guidance for percutaneous coronary intervention (PCI), there are pertinent caveats that warrant closer inspection.
While contrast-enhanced mammography (CEM) offered the highest agreement with histopathology on the extent of malignancy in a new study, researchers found the use of pre-op CEM had no impact on mastectomy or reoperation rates.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
New Study Shows Benefits of AI Analysis for Ultrasound Reports and Incidental Findings of Hepatic Steatosis
2
Next-Generation Breast Imaging Platform to be Unveiled at RSNA
3
What a New Prospective RCT Reveals About Contrast-Enhanced Mammography in Breast Cancer Staging
4
Diagnostic Imaging’s Weekly Scan: November 1 — November 7
5